| ACINX | OSMYX | ACINX / OSMYX | |
| Total Expense Ratio | 0.97 | 1.18 | 82% |
| Annual Report Gross Expense Ratio | 1.04 | 1.18 | 88% |
| Fund Existence | 34 years | 21 years | - |
| Gain YTD | 7.125 | 10.559 | 67% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 1000 | 200% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 798M | 2.41B | 33% |
| Annual Yield % from dividends | 1.79 | 1.57 | 114% |
| Returns for 1 year | 4.44 | -6.21 | -72% |
| Returns for 3 years | 9.13 | -0.12 | -7,353% |
| Returns for 5 years | -33.28 | -37.56 | 89% |
| Returns for 10 years | -35.47 | 7.30 | -486% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XJAN | 39.20 | N/A | N/A |
| FT Vest US Eq Enh & Mod Buf ETF-Jan | |||
| MSLC | 60.85 | -0.24 | -0.39% |
| Morgan Stanley Pathway Large Cap Eq ETF | |||
| PQUS | 28.59 | -0.12 | -0.41% |
| Pictet AI Enhanced US Equity ETF | |||
| BINV | 45.37 | -0.23 | -0.50% |
| Brandes International ETF | |||
| WDNA | 23.08 | -0.35 | -1.49% |
| WisdomTree BioRevolution ETF | |||